New Pancreatic Cancer Treatment May Add Years to the Lives of Those Facing Death

Last year, a 74-year old woman was diagnosed with inoperable pancreatic cancer. Her family turned to Miami Cancer Institute in their search for treatment options. Since her diagnosis, she became part of the TIGeR-PaC clinical trial, and is now in a maintenance phase and says her quality of life has improved.

View the entire article on the Miami Herald

Previous Post
RenovoRx Named 2020 Winner in the Fierce Innovation Awards for Life Sciences
Next Post
RenovoRx Continues with Strong Momentum and Reaches Milestone of 100th Patient Enrolled in its Phase III TIGeR-PaC Clinical Trial